Abstract:The application of CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) technologies in zebrafish has the potential to expand its capacity for the study of gene function significantly. We have developed a codon optimized CRISPRi/a for zebrafish; here we provide proof-of-principle data across established pigmentary and growth phenotypes. We established a zebrafish codon-optimized cas9 gene, harboring mutations D10A and D839A to render the protein catalytically inactive ( ). Similarly, codon-optimized Krüppel associated box (KRAB) and methylated CP2 (MeCP2) inactivating domains or VP64 activator domain were cloned downstream from for CRISPRi and CRISPRa, respectively. To validate CRISPRi, we targeted key genes in melanocyte differentiation ( and ); and melanin production (tyrosinase; ). Microinjection of CRISPRi mRNA and single guide RNAs (sgRNAs) targeting the promoter or 5′-UTR resulted in larvae with hypopigmented epidermal melanocytes. Transcription factors mitfa and mitfb similarly direct differentiation and pigmentation of epidermal melanocytes ( ) and retinal pigment epithelium (RPE, ). CRISPRi-mediated targeting of their promoters or 5′-UTR also results in pronounced hypopigmentation of epidermal melanocytes ( ), and RPE ( ). So too, targeting CRISPRi to the promoter results in hypopigmentation of both epidermal melanocytes and RPE consistent with its role upstream of and , and . Finally, we asked whether CRISPRi and CRISPRa could be used to modulate a single gene, to yield hypomorphic and hypermorphic effects, selecting , as our target. This gene regulates energy homeostasis and somatic growth via inhibition of the melanocortin 4 receptor gene ( ). We demonstrate that targeting the 5′-UTR with CRISPRa or CRISPRi significantly increases or decreases larval body length, respectively. We demonstrate the utility of CRISPRi/a for modulating control of zebrafish gene expression, facilitating efficient assay of candidate gene function and disease relevance.

Epigallocatechin gallate attenuates neurocognitive impairment in CRISPR-CAS9-induced knockout of DYRK1A gene in zebrafish model

Zebrafish Knockout of Frk Gene Shows Social Impairments Relevant to Autism and Delays Brain Development by Increasing Cell Proliferation

Evaluation of the therapeutic potential of Epigallocatechin-3-gallate (EGCG) via oral gavage in young adult Down syndrome mice

EGCG-like non-competitive inhibitor of DYRK1A rescues cognitive defect in a down syndrome model

CRISPR/Cas9 Sistemi Kullanılarak Ectodysplasin A (eda) İfade Etmeyen Zebra Balığı Üretimi

Effects of two chd2-knockout strains on the morphology and behavior in zebrafish

Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome

Efficient Generation of Zebrafish Maternal-Zygotic Mutants Through Transplantation of Ectopically Induced and Cas9/gRNA Targeted Primordial Germ Cells

Brain transcriptome study through CRISPR/Cas9 mediated mouse Dip2c gene knock-out

Efficient generation of zebrafish maternal-zygotic mutants through transplantation of ectopically induced and Cas9/gRNA targeted PGCs

CRISPR-Cas9-mediated Precise Knock-in Edits in Zebrafish Hearts

Optimized CRISPR inhibition and activation opens key avenues for systematic biological exploration in zebrafish.

AP-4 loss in CRISPR-edited zebrafish affects early embryo development

Improving the Efficiency for Generation of Genome-Edited Zebrafish by Labeling Primordial Germ Cells

Significant Influence on Nervous System Development in dync1h1-knockout Zebrafish Via CRISPR/Cas9 Technology

Establishment of a Dihydrofolate Reductase Gene Knock-In Zebrafish Strain to Aid Preliminary Analysis of Congenital Heart Disease Mechanisms.

Brain transcriptome profile after CRISPR-induced ghrelin mutations in zebrafish

Molecular Rescue of Dyrk1A Overexpression Alterations in Mice with Fontup® Dietary Supplement: Role of Green Tea Catechins

Single nucleotide polymorphism in the genomic target affects the recombination efficiency of CRISPR/Cas9-mediated gene editing in zebrafish

CA1 pyramidal neuron gene expression mosaics in the Ts65Dn murine model of Down syndrome and Alzheimer's disease following maternal choline supplementation

Crispr/Cas9-Mediated Grna Gene Knockout Leads To Neurodevelopmental Defects And Motor Behavior Changes In Zebrafish